The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Some Coronary Risk Factors Related to the Insulin Resistance Syndrome and Treatment With Gemfibrozil: Experience From the Helsinki Heart Study
Abstract
Background Coronary risk factors related to the insulin resistance syndrome tend to cluster in the same individual. Our previous studies have shown that the dyslipidemia characteristic of this syndrome—low HDL cholesterol and high triglyceride (TG) levels—responds well to treatment with gemfibrozil. Most factors related to insulin-resistance syndrome decrease fibrinolytic capacity, whereas a recent study showed that gemfibrozil improves it and thus may attenuate thrombotic events. To discover whether subjects with clustering of factors related to this resistance might in particular benefit from gemfibrozil, we reanalyzed the Helsinki Heart Study data. Methods and Results We used Cox regression models to explore the effects of gemfibrozil among overweight subjects with additional coronary risk factors in this hypercholesterolemic male population of 2046 subjects randomized to gemfibrozil and 2035 to placebo. The effect of gemfibrozil was largely confined to overweight subjects: among those with body mass index (BMI) >26 kg/m 2 , the net difference in cardiac end points between gemfibrozil and placebo groups was 21 (25 of 1119 versus 46 of 1081), and in those with BMI ≤26 kg/m 2 , it was 7 (31 of 927 versus 38 of 954). The risk reduction with gemfibrozil was 78% ( P =.002) among those with BMI >26 kg/m 2 and dyslipidemia (TG ≥2.3 mmol/L and HDL cholesterol <1.08 mmol/L). Among those with BMI >26 kg/m 2 and three or four of the following factors present—smoking, sedentary lifestyle, blood pressure ≥140/90 mm Hg, or blood glucose >4.4 mmol/L—the risk reduction was 68% ( P =.03). Conclusions Gemfibrozil reduced the coronary risk mainly in overweight subjects with additional risk factors known to contribute to the insulin-resistance syndrome or predispose to it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Self-citationManninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329
Self-citationRegional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
Is the relationship between blood pressure and cardiovascular risk dependent on body mass index?
CAMBIEN, F., CHRETIEN, J. M., DUCIMETIERE, P., GUIZE, L., & RICHARD, J. L. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114124 · Cited by 89
Research works printed but not linked: 25
- 10.7326/0003-4819-103-6-1010 · DOI · Paper page
- 10.3109/07853899209164140 · DOI · Paper page
- Stanton JL Braitman LE Riley AM Khoo C-S Smith JL. Demographic dietary life style and anthropometric correlates of blood pressure. Hypertension. 1982;4(suppl III):III-135-III-142. · DOI
- 10.2337/diab.41.7.826 · DOI · Paper page
- 10.2337/diab.37.12.1595 · DOI · Paper page
- 10.1016/0140-6736(92)90730-Q · DOI · Paper page
- 10.1016/0002-9149(92)90981-4 · DOI
- Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier Aillaud MF, Atlan C. Relationships between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor 1. Diabetes Metab. 1987;13:331-336.
- 10.1161/atv91.12.3.1547186 · doi:10.1161/atv91.12.3.1547186
- 10.1161/circ.89.1.8281664 · doi:10.1161/circ.89.1.8281664
- 10.1016/S0140-6736(87)93050-9 · DOI · Paper page
- 10.1111/j.1365-2796.1993.tb00688.x · DOI
- Mänttäri M, Elo O, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Mäenpää H, Mälkönen M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA. The Helsinki Heart Study: basic design and randomization procedure. Eur Heart J. 1987;8:1-29.
- 10.1055/s-0038-1648481 · DOI
- 10.1161/circ.85.5.1572044 · doi:10.1161/circ.85.5.1572044
- 10.1093/oxfordjournals.eurheartj.a062547 · DOI · Paper page
- Wilhelmsen L Tibblin G Fodor J Werkö L. A multifactorial primary preventive trial in Gothenburg Sweden. In: Larson OA Malmborg RO eds. Coronary Heart Disease and Physical Fitness. Copenhagen: Munksgaard; 1971:266-270.
- Dixon WJ ed. BMDP Statistical Software Manual. Berkeley/Los Angeles/Oxford: University of California Press; 1990.
- 10.1161/circ.89.2.8313558 · doi:10.1161/circ.89.2.8313558
- 10.1111/j.1365-2796.1991.tb00352.x · DOI
- 10.1161/atv91.13.10.8399084 · doi:10.1161/atv91.13.10.8399084
- 10.1161/atv91.13.1.8422338 · doi:10.1161/atv91.13.1.8422338
- 10.1161/atv91.12.1.1310024 · doi:10.1161/atv91.12.1.1310024
- 10.1111/j.1365-2796.1994.tb01029.x · DOI
- 10.1055/s-2007-1002671 · doi:10.1055/s-2007-1002671
Cited by
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
Sorting out the roles of PPAR in energy metabolism and vascular homeostasis
Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962
Therapeutic roles of peroxisome proliferator-activated receptor agonists
Staels, B., & Fruchart, J.-C. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2460 · Cited by 646
Rubins, H. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2597 · Cited by 586
Metadata
- Authors
- Tenkanen, L., Mänttäri, M., & Manninen, V.
- Venue
- Circulation
- Published
- 1995-10
- Volume
- 92
- Issue
- 7
- Pages
- 1779-1785
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2108886453
- Cited by
- 188
- References
- 4
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Some Coronary Risk Factors Related to the Insulin Resistance Syndrome and Treatment With Gemfibrozil: Experience From the Helsinki Heart Study. https://app.cochat.ai/papers/10.1161/01.cir.92.7.1779
- The paper
- Tenkanen, L., Mänttäri, M., & Manninen, V. (1995). Some Coronary Risk Factors Related to the Insulin Resistance Syndrome and Treatment With Gemfibrozil: Experience From the Helsinki Heart Study. Circulation. https://doi.org/10.1161/01.cir.92.7.1779
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.